Bhadelia, Nahid, M.D., M.A.

Medical School: Tufts University School of Medicine, Boston
Graduate School: Fletcher School of Law and Diplomacy
Residency training: Mount Sinai Hospital, New York
Fellowship training: Columbia Presbyterian Hospital, New YorkBhadelia2

 

Dr. Nahid Bhadelia is an infectious diseases physician and the medical director of Special Pathogens Unit at Boston University School of Medicine. She oversees the medical response program for Boston University’s maximum containment biosafety level 4 program at National Emerging Infectious Diseases Laboratories. She serves on national and interagency groups focused on medical countermeasures, the intersection between public health preparedness, research and clinical care for emerging pathogens. Her research focuses on identification of safe and effective clinical interventions and infection control measures related to viral hemorrhagic fevers.

During the West African Ebola epidemic, she served as a clinician in several Ebola treatment units, working with World Health Organization and Partners in Health. She currently serves as the clinical lead for the Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) program which a joint US-Ugandan effort to create clinical research capacity to combat viral hemorrhagic fevers in Uganda at the border of Democratic Republic of Congo.

She has served as a subject matter expert to US Centers for Disease Control and Prevention, Department of Defense, Global Fund to Fight AIDS, Tuberculosis and Malaria, and World Bank.

Dr. Bhadelia is an Assistant Professor at the Institute of Human Security at the Tufts Fletcher School of Law and Diplomacy, where she teaches a course on human security and emerging infectious diseases.

 

Publications